Xiao Yuan, Yuan Wentao, Yu Bo, Guo Yan, Xu Xu, Wang Xinqiong, Yu Yi, Yu Yi, Gong Biao, Xu Chundi
Pediatric Department, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China.
Department of Genetics, Shanghai-MOST Key Laboratory of Health and Disease Genomics, Chinese National Human Genome Center and Shanghai Industrial Technology Institute (SITI), Shanghai, China.
J Pediatr. 2017 Dec;191:158-163.e3. doi: 10.1016/j.jpeds.2017.08.063.
To identify causal mutations in certain genes in children with acute recurrent pancreatitis (ARP) or chronic pancreatitis (CP).
After patients were enrolled (CP, 55; ARP, 14) and their clinical characteristics were investigated, we performed next-generation sequencing to detect nucleotide variations among the following 10 genes: cationic trypsinogen protease serine 1 (PRSS1), serine protease inhibitor, Kazal type 1 (SPINK1), cystic fibrosis transmembrane conductance regulator gene (CFTR), chymotrypsin C (CTRC), calcium-sensing receptor (CASR), cathepsin B (CTSB), keratin 8 (KRT8), CLAUDIN 2 (CLDN2), carboxypeptidase A1 (CPA1), and ATPase type 8B member 1 (ATP8B1). Mutations were searched against online databases to obtain information on the cause of the diseases. Certain novel mutations were analyzed using the SIFT2 and Polyphen-2 to predict the effect on protein function.
There were 45 patients with CP and 10 patients with ARP who harbored 1 or more mutations in these genes; 45 patients had at least 1 mutation related to pancreatitis. Mutations were observed in the PRSS1, SPINK1, and CFTR genes in 17 patients, the CASR gene in 5 patients, and the CTSB, CTRC, and KRT8 genes in 1 patient. Mutations were not found in the CLDN, CPA1, or ATP8B1 genes. We found that mutations in SPINK1 may increase the risk of pancreatic duct stones (OR, 11.07; P = .003). The patients with CFTR mutations had a higher level of serum amylase (316.0 U/L vs 92.5 U/L; P = .026).
Mutations, especially those in PRSS1, SPINK1, and CFTR, accounted for the major etiologies in Chinese children with CP or ARP. Children presenting mutations in the SPINK1 gene may have a higher risk of developing pancreatic duct stones.
鉴定急性复发性胰腺炎(ARP)或慢性胰腺炎(CP)患儿某些基因中的致病突变。
纳入患者(CP患者55例,ARP患者14例)并调查其临床特征后,我们进行了二代测序,以检测以下10个基因中的核苷酸变异:阳离子胰蛋白酶原蛋白酶丝氨酸1(PRSS1)、丝氨酸蛋白酶抑制剂Kazal型1(SPINK1)、囊性纤维化跨膜传导调节因子基因(CFTR)、糜蛋白酶C(CTRC)、钙敏感受体(CASR)、组织蛋白酶B(CTSB)、角蛋白8(KRT8)、紧密连接蛋白2(CLDN2)、羧肽酶A1(CPA1)和ATP酶8B成员1(ATP8B1)。针对在线数据库搜索突变,以获取疾病病因信息。使用SIFT2和Polyphen - 2分析某些新突变,以预测其对蛋白质功能的影响。
45例CP患者和10例ARP患者在这些基因中携带1个或更多突变;45例患者至少有1个与胰腺炎相关的突变。17例患者的PRSS1、SPINK1和CFTR基因中观察到突变,5例患者的CASR基因中观察到突变,1例患者的CTSB、CTRC和KRT8基因中观察到突变。CLDN、CPA1或ATP8B1基因中未发现突变。我们发现SPINK1突变可能增加胰管结石风险(比值比,11.07;P = 0.003)。CFTR突变患者的血清淀粉酶水平较高(316.0 U/L对92.5 U/L;P = 0.026)。
突变,尤其是PRSS1、SPINK1和CFTR中的突变,是中国CP或ARP患儿的主要病因。SPINK1基因出现突变的儿童发生胰管结石的风险可能更高。